Mepacrine treatment prevents immobilization-induced desensitization of beta-adrenergic receptors in rat hypothalamus and brain stem

Abstract

Forced immobilization is a severe stress in rats which diminishes levels of epinephrine in specific nuclei in the hypothalamus and brain stem, suggesting that release of epinephrine is stimulated to a rate which exceeds the rate of its replacement. In the pineal gland, frog erythrocytes, C 6 astrocytoma cells and rat brain, β-adrenoceptor agonists appear to regulate the number of their receptors. Exposure to high concentrations of an agonist leads to apparent decrease in receptors reflected by a decrease in maximal specific binding of antagonists. The apparent decreases in receptors have been shown to be attended by decreases in physiologic responsiveness. In C 6 astrocytoma cells, β-agonists stimulate methylation of phosphatidylethanolamine to increase formation of membrane phosphatidylcholine which in turn appears to enhance activation of adenyl cyclase. Interference with the metabolism of phospholipids by exposure to phospholipase A 2 inhibitor, mepacrine (quinacrine), prevents agonist-induced desensitization of β-adrenoceptors in astrocytoma cells. In the present study repeated immobilization stress has been found to decrease significantly the number of β-adrenoceptors in hypothalamus and brain stem while increasing the number ofα 2-adrenoceptors. The desensitization of beta-adrenoceptors was prevented by treatment with mepacrine.